Clinical Trials in Michigan

Showing 4081-4100 of 16,154 trials

Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

NCT06391073

Emergency department visits provide an opportunity to identify people with undiagnosed, untreated, or uncontrolled high blood pressure. In Reach Out, we will test whether a mobile health intervention yields a greater reduction in blood pressure than usual care among individuals identified with high blood pressure during a safety-net emergency department visit. Subsequently, we will estimate the reduction in heart attack, stroke, and dementia if Reach Out were implemented across all U.S. safety-net emergency departments.

Hypertension

Northwestern University500 participantsStarted Jul 2024

Flint, Michigan, United States

COMPLETEDNA94 miles

This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.

NCT06666426

This post-market study will assess the performance of and user experience with the PureWick™ System in a home setting. The study will also observe safety of the study device and collect information from participants about their quality of life before and after using the device.

Adult Nocturnal EnuresisUrinary Incontinence (UI)

C. R. Bard171 participantsStarted Oct 2024

Guntersville, Alabama, United States • Chandler, Arizona, United States • Eagle Rock, California, United States +12 more locations

Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.

Find Trials by Condition in Michigan

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration

Study Evaluating the Safety and Efficacy of AR-15512

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Secur-Fit Advanced Outcomes Study

Rhythm Express Wearable System vs. Simultaneous Polysomnography for the Diagnosis of Obstructive Sleep Apnea in Adults With Suspected or Observed Atrial Fibrillation

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

Open-Label Surufatinib in European Patients With NET